What is Cytarabine-Idarubicin?

Category: Prescription Drugs


See also: Cytarabine Idarubicin

This regimen is used to consolidate remission in acute myelogenous leukemia and includes Cytarabine (Ara-C, Cytosar-U) and Idarubicin (Idamycin). The duration of varies by protocol.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 0

Commonly reported side effects and conditions associated with Cytarabine-Idarubicin

Side effect Patients
Nausea and vomiting 1

Why patients stopped taking Cytarabine-Idarubicin

Multiple reasons could be selected

Reason Patients
Course of treatment ended 1
See 1 patient who's stopped taking Cytarabine-Idarubicin


Stopped taking Cytarabine-Idarubicin

Duration Patients
Less than 1 month 1
Last updated:
There are no evaluations for Cytarabine-Idarubicin.